Related references
Note: Only part of the references are listed.Randomized, double-blinded placebo-controlled study of a catalytic compound, JTT-305, in patients with postmenopausal osteoporosis
S. Fukumoto et al.
BONE (2011)
JTT-305, an orally active calcium-sensing receptor antagonist, stimulates transient parathyroid hormone release and bone formation in ovariectomized rats
Shuichi Kimura et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
The Effects of Ronacaleret, a Calcium-Sensing Receptor Antagonist, on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Women with Low Bone Mineral Density
Lorraine A. Fitzpatrick et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Discovery of a Potent and Short-Acting Oral Calcilytic with a Pulsatile Secretion of Parathyroid Hormone
Yuko Shinagawa et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone
J.M. Hock et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Effect of Transdermal Teriparatide Administration on Bone Mineral Density in Postmenopausal Women
Felicia Cosman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
A mathematical model of parathyroid hormone response to acute changes in plasma ionized calcium concentration in humans
Rajiv P. Shrestha et al.
MATHEMATICAL BIOSCIENCES (2010)
Mechanism-Based Pharmacokinetic/Pharmacodynamic Model of Parathyroid Hormone-Calcium Homeostasis in Rats and Humans
Anson K. Abraham et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Mechanisms of anabolic therapies for osteoporosis
Ernesto Canalis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The circadian rhythm of osteoprotegerin and its association with parathyroid hormone secretion
F. Joseph et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Molecular and cellular mechanisms of the anabolic effect of intermittent PTH
Robert L. Jilka
BONE (2007)
Recombinant full-length parathyroid hormone (1-84)
Marit D. Moen et al.
DRUGS (2006)
Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure
CA Frolik et al.
BONE (2003)
Diversity of mechanism-based pharmacodynamic models
DE Mager et al.
DRUG METABOLISM AND DISPOSITION (2003)
The search for calcium receptor antagonists (calcilytics)
EF Nemeth
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2002)
Share Paper
